作者
Ting Gong,Linzheng Liao,Yong Tang,Weiwei Liu,Ling Yao,Zhen Wu,Jackson Liang Yao Li,Fulai Bai,Qian Zhang,Liling Tang
摘要
Constipation is a common gastrointestinal disorder, and while L-arabinose has been shown to relieve it, the exact molecular mechanisms remain unclear. This study investigated the effects of L-arabinose in constipated rat at doses of 400, 600, and 800 mg/kg body weight (B.W.). The 800 mg/kg B.W. dose significantly improved overall physiological state, stool consistency, intestinal transit, and gastric emptying. It also improved gastric, liver, and kidney function, while modulating key gastrointestinal peptides, including motilin (MTL), substance P (SP), vasoactive intestinal peptide (VIP), acetylcholinesterase (AchE), endothelin-1 (ET-1), serotonin (5-HT), somatostatin (SS), gastrin (Gas), and nitric oxide (NO). In addition, the 800 mg/kg dose notably increased goblet cell numbers, mucus layer thickness, and beneficial gut microbes such as Ruminococcus flavefaciens and Muribaculum intestinale . It also upregulated the expression of Cd38, Phlpp2, Muc3, and Acat2 , while downregulating Cd34 , C1qa , and C1qc. These results indicate that L-arabinose not only alleviates constipation but also enhances immune function and regulates signaling pathways, restoring gastrointestinal peptides to near-normal levels. • L-arabinose alleviates constipation by regulating gastrointestinal associated peptides. • L-arabinose increases the relative abundance of Ruminococcus flavefaciens and Muribaculum intestinale to improve constipation. • L-arabinose regulates intestinal rhythmicity by up-regulating Phlpp2 to alleviate constipation.